Jonathan Ho, a technology transfer fellow at the National Cancer Institute (NCI) of the National Institutes of Health (NIH), has been appointed as a technology transfer licensing associate in the Office of Research of the University of Notre Dame Graduate School.
The technology transfer office serves Notre Dame faculty and protects the Universitys intellectual property by evaluating, patenting, marketing and licensing Notre Dame inventions. Ho will assume his new position Feb. 1.
At the NCI, Ho is responsible for certain compliance, reporting and inventor service duties, and has received patent agent training, in the institutes technology transfer division. He previously was a bench scientist with Prolexys Pharmaceuticals Inc. inSalt Lake City, where he and his team of researchers worked on protein purification and expression, as well as other drug discovery protocols.
After earning his doctorate in physiology from theUniversityofVirginia, Ho served as a post-doctoral student in the NIH laboratories of the National Institute of Diabetes and Digestive and Kidney Diseases. He received an NIH Fellows Award for Research Excellence in 2001.
Ho has been published in several peer-reviewed journals and has a patent pending on work related to his protein purification research.